{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:22:24Z","timestamp":1753521744182,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015660","name":"UCB Celltech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10072-024-07336-8","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T11:47:19Z","timestamp":1706183239000},"page":"2321-2324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6452-4765","authenticated-orcid":false,"given":"Ali","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Fryk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Rudnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Vanderkelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Scowcroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerina","family":"Bonar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"7336_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/s0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S et al (2022) Amyotrophic lateral sclerosis. Lancet 400:1363\u20131380. https:\/\/doi.org\/10.1016\/s0140-6736(22)01272-7","journal-title":"Lancet"},{"key":"7336_CR2","doi-asserted-by":"publisher","first-page":"12408","DOI":"10.1038\/ncomms12408","volume":"7","author":"KC Arthur","year":"2016","unstructured":"Arthur KC, Calvo A, Price TR et al (2016) Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun 7:12408. https:\/\/doi.org\/10.1038\/ncomms12408","journal-title":"Nat Commun"},{"key":"7336_CR3","doi-asserted-by":"publisher","unstructured":"Mehta P, Kaye W, Raymond J et al (2018) Prevalence of amyotrophic lateral sclerosis - United States, 2014. MMWR Morb Mortal Wkly Rep 67:216\u2013218. https:\/\/doi.org\/10.15585\/mmwr.mm6707a3","DOI":"10.15585\/mmwr.mm6707a3"},{"key":"7336_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162\u2013172. https:\/\/doi.org\/10.1056\/NEJMra1603471","journal-title":"N Engl J Med"},{"key":"7336_CR5","doi-asserted-by":"publisher","unstructured":"[Anonymous] (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459\u2013480. https:\/\/doi.org\/10.1016\/s1474-4422(18)30499-x","DOI":"10.1016\/s1474-4422(18)30499-x"},{"key":"7336_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","volume":"79","author":"S Witzel","year":"2022","unstructured":"Witzel S, Maier A, Steinbach R et al (2022) Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis. JAMA Neurol 79:121\u2013130. https:\/\/doi.org\/10.1001\/jamaneurol.2021.4893","journal-title":"JAMA Neurol"},{"key":"7336_CR7","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1007\/s10072-023-06869-8","volume":"44","author":"AZ Nourelden","year":"2023","unstructured":"Nourelden AZ, Kamal I, Hagrass AI et al (2023) Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurol Sci 44:3429\u20133442. https:\/\/doi.org\/10.1007\/s10072-023-06869-8","journal-title":"Neurol Sci"},{"key":"7336_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3109\/21678421.2014.887119","volume":"15","author":"WE Kaye","year":"2014","unstructured":"Kaye WE, Sanchez M, Wu J (2014) Feasibility of creating a National ALS Registry using administrative data in the United States. Amyotroph Lateral Scler Frontotemporal Degener 15:433\u2013439. https:\/\/doi.org\/10.3109\/21678421.2014.887119","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"7336_CR9","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s00415-006-0195-y","volume":"253","author":"CA Johnston","year":"2006","unstructured":"Johnston CA, Stanton BR, Turner MR et al (2006) Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol 253:1642\u20131643. https:\/\/doi.org\/10.1007\/s00415-006-0195-y","journal-title":"J Neurol"},{"key":"7336_CR10","doi-asserted-by":"publisher","unstructured":"Horrocks S, Wilkinson T, Schnier C et al (2017) Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: a systematic review. PLoS ONE 12:e0172639. https:\/\/doi.org\/10.1371\/journal.pone.0172639","DOI":"10.1371\/journal.pone.0172639"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07336-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07336-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07336-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:43:55Z","timestamp":1713242635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07336-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["7336"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07336-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UCB Pharma has no role in data collection, analysis the management, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for journal publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the funder\/Sponsor"}},{"value":"The views expressed are those of the authors and do not necessarily reflect the official position of UCB Pharma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"KB, MV and AS are employees of UCB Pharma. AA, RW, HF, and JR reports contract work with UCB Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}